Cantitate/Preț
Produs
Total produse
Vezi coșul
Antidepressants: New Pharmacological Strategies de Phil Skolnick

Antidepressants: New Pharmacological Strategies: Contemporary Neuroscience

Editat de Phil Skolnick
en Limba Engleză Hardback – 3 iun 1997
In this book, leading-edge investigators offer effective strategies to improve current antidepressive therapies and suggest molecular, biological, and genetic approaches that will lead to the development of novel antidepressants. The contributors' critical reviews and commentaries illuminate our understanding of the mechanism(s) responsible for antidepressant action. The book's goal is to move beyond current biogenic amine-based concepts and therapies to the development of new and improved antidepressants that are more effective and have a more rapid onset than current.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 115338 lei  6-8 săpt.
  Humana Press Inc. – 19 noi 2010 115338 lei  6-8 săpt.
Hardback (1) 116382 lei  6-8 săpt.
  Humana Press Inc. – 3 iun 1997 116382 lei  6-8 săpt.

Din seria Contemporary Neuroscience

Preț: 116382 lei

Preț vechi: 141930 lei
-18% Nou

Puncte Express: 1746
Preț estimativ în valută:
22279€ • 24270$ • 18690£

Carte tipărită la comandă

Livrare economică 19 decembrie 24 - 02 ianuarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780896034693
ISBN-10: 0896034690
Pagini: 257
Ilustrații: X, 257 p.
Dimensiuni: 178 x 254 x 20 mm
Greutate: 0.79 kg
Ediția:1997
Editura: Humana Press Inc.
Colecția Humana
Seria Contemporary Neuroscience

Locul publicării:Totowa, NJ, United States

Public țintă

Research

Cuprins

1 Strategies to Optimize the Antidepressant Action of Selective Serotonin Reuptake Inhibitors.- 2 Antidepressant Properties of Specific Serotonin-Noradrenaline Reuptake Inhibitors.- 3 5-HT-Moduline: Novel Therapeutic Strategy for Antidepressant Action.- 4 Reversible Inhibitors of Monoamine Oxidase A (RIMAs): Where Can We Go from Here?.- 5 Calcium Channel Antagonists in Mood Disorders.- 6 Functional NMDA Antagonists: A New Class of Antidepressant Agents.- 7 Is an Adaptation of NMDA Receptors an Obligatory Step in Antidepressant Action?.- 8 NMDA Receptors and Affective Disorders.- 9 The Potential Contribution of Sigma Receptors to Antidepressant Actions.- 10 A Role for CREB in Antidepressant Action.- 11 Antidepressants: Beyond the Synapse.- 12 Animal Models to Detect Antidepressants: Are New Strategies Necessary to Detect New Agents?.- 13 Molecular Strategies to Novel Antidepressant Discovery.

Recenzii

"This is a timely, much needed addition to the library of a psychopharmacology researcher who is interested in developing new studies in the field of antidepressant functioning or who needs a thorough update on cutting edge antidepressant pharmacology and theory."-Doody's Health Sciences Book Review Journal

Textul de pe ultima copertă

In Antidepressants: Current Trends and Future Directions, leading-edge investigators distill the dramatic recent advances in our understanding of the mechanisms responsible for antidepressant action. The authoritative contributors offer strategies to improve current therapies grounded on biogenic amine-based concepts. By departing from traditional strategies, the authors offer alternatives to therapies that often work too slowly or not at all, and suggest how the many recent advances in molecular biology and genetics might best be exploited in the design of optimal new therapies.

Antidepressants: Current Trends and Future Directions summarizes novel concepts of antidepressant therapy that attempt to exploit provocative new insights from the laboratory to improve current, biogenic amine-based therapies. Readers will find the book an exceptional resource in opening the door to the development of newer and more effective antidepressant therapies.